Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation

Michaela Livia Bajenaru, Yuan Zhu, Nicolé M. Hedrick, Jessica Donahoe, Luis F. Parada, David H. Gutmann

Research output: Contribution to journalArticle

210 Citations (Scopus)

Abstract

Individuals with the neurofibromatosis 1 (NF1) inherited tumor syndrome develop low-grade gliomas (astrocytomas) at an increased frequency, suggesting that the NF1 gene is a critical growth regulator for astrocytes. In an effort to determine the contribution of the NF1 gene product, neurofibromin, to astrocyte growth regulation and NF1-associated astrocytoma formation, we generated astrocyte-specific Nf1 conditional knockout mice (Nf1GFAPCKO) by using Cre/LoxP technology. Transgenic mice were developed in which Cre recombinase was specifically expressed in astrocytes by embryonic day 14.5. Successive intercrossing with mice bearing a conditional Nf1 allele (Nf1flox) resulted in GFAP-Cre Nf1flox/flox (Nf1GFAPCKO) animals. No astrocytoma formation or neurological impairment was observed in Nf1GFAPCKO mice after 20 months, but increased numbers of proliferating astrocytes were observed in several brain regions. To determine the consequence of Nf1 inactivation at different developmental times, the growth properties of embryonic day 12.5 and postnatal day 2 Nf1 null astrocytes were analyzed. Nf1 null astrocytes exhibited increased proliferation but lacked tumorigenic properties in vitro and did not form tumors when injected into immunocompromised mouse brains in vivo. Collectively, our results suggest that loss of neurofibromin is not sufficient for astrocytoma formation in mice and that other genetic or environmental factors might influence NF1-associated glioma tumorigenesis.

Original languageEnglish
Pages (from-to)5100-5113
Number of pages14
JournalMolecular and Cellular Biology
Volume22
Issue number14
DOIs
StatePublished - Jul 9 2002
Externally publishedYes

Fingerprint

Neurofibromatosis 1 Genes
Astrocytoma
Astrocytes
Neurofibromin 1
Glioma
Growth
Neurofibromatosis 1
Brain
Knockout Mice
Transgenic Mice
Genes
Neoplasms
Carcinogenesis
Alleles
Technology

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. / Bajenaru, Michaela Livia; Zhu, Yuan; Hedrick, Nicolé M.; Donahoe, Jessica; Parada, Luis F.; Gutmann, David H.

In: Molecular and Cellular Biology, Vol. 22, No. 14, 09.07.2002, p. 5100-5113.

Research output: Contribution to journalArticle

Bajenaru, Michaela Livia ; Zhu, Yuan ; Hedrick, Nicolé M. ; Donahoe, Jessica ; Parada, Luis F. ; Gutmann, David H. / Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. In: Molecular and Cellular Biology. 2002 ; Vol. 22, No. 14. pp. 5100-5113.
@article{394f91a004e240ebb54b919c66cbb192,
title = "Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation",
abstract = "Individuals with the neurofibromatosis 1 (NF1) inherited tumor syndrome develop low-grade gliomas (astrocytomas) at an increased frequency, suggesting that the NF1 gene is a critical growth regulator for astrocytes. In an effort to determine the contribution of the NF1 gene product, neurofibromin, to astrocyte growth regulation and NF1-associated astrocytoma formation, we generated astrocyte-specific Nf1 conditional knockout mice (Nf1GFAPCKO) by using Cre/LoxP technology. Transgenic mice were developed in which Cre recombinase was specifically expressed in astrocytes by embryonic day 14.5. Successive intercrossing with mice bearing a conditional Nf1 allele (Nf1flox) resulted in GFAP-Cre Nf1flox/flox (Nf1GFAPCKO) animals. No astrocytoma formation or neurological impairment was observed in Nf1GFAPCKO mice after 20 months, but increased numbers of proliferating astrocytes were observed in several brain regions. To determine the consequence of Nf1 inactivation at different developmental times, the growth properties of embryonic day 12.5 and postnatal day 2 Nf1 null astrocytes were analyzed. Nf1 null astrocytes exhibited increased proliferation but lacked tumorigenic properties in vitro and did not form tumors when injected into immunocompromised mouse brains in vivo. Collectively, our results suggest that loss of neurofibromin is not sufficient for astrocytoma formation in mice and that other genetic or environmental factors might influence NF1-associated glioma tumorigenesis.",
author = "Bajenaru, {Michaela Livia} and Yuan Zhu and Hedrick, {Nicol{\'e} M.} and Jessica Donahoe and Parada, {Luis F.} and Gutmann, {David H.}",
year = "2002",
month = "7",
day = "9",
doi = "10.1128/MCB.22.14.5100-5113.2002",
language = "English",
volume = "22",
pages = "5100--5113",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "14",

}

TY - JOUR

T1 - Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation

AU - Bajenaru, Michaela Livia

AU - Zhu, Yuan

AU - Hedrick, Nicolé M.

AU - Donahoe, Jessica

AU - Parada, Luis F.

AU - Gutmann, David H.

PY - 2002/7/9

Y1 - 2002/7/9

N2 - Individuals with the neurofibromatosis 1 (NF1) inherited tumor syndrome develop low-grade gliomas (astrocytomas) at an increased frequency, suggesting that the NF1 gene is a critical growth regulator for astrocytes. In an effort to determine the contribution of the NF1 gene product, neurofibromin, to astrocyte growth regulation and NF1-associated astrocytoma formation, we generated astrocyte-specific Nf1 conditional knockout mice (Nf1GFAPCKO) by using Cre/LoxP technology. Transgenic mice were developed in which Cre recombinase was specifically expressed in astrocytes by embryonic day 14.5. Successive intercrossing with mice bearing a conditional Nf1 allele (Nf1flox) resulted in GFAP-Cre Nf1flox/flox (Nf1GFAPCKO) animals. No astrocytoma formation or neurological impairment was observed in Nf1GFAPCKO mice after 20 months, but increased numbers of proliferating astrocytes were observed in several brain regions. To determine the consequence of Nf1 inactivation at different developmental times, the growth properties of embryonic day 12.5 and postnatal day 2 Nf1 null astrocytes were analyzed. Nf1 null astrocytes exhibited increased proliferation but lacked tumorigenic properties in vitro and did not form tumors when injected into immunocompromised mouse brains in vivo. Collectively, our results suggest that loss of neurofibromin is not sufficient for astrocytoma formation in mice and that other genetic or environmental factors might influence NF1-associated glioma tumorigenesis.

AB - Individuals with the neurofibromatosis 1 (NF1) inherited tumor syndrome develop low-grade gliomas (astrocytomas) at an increased frequency, suggesting that the NF1 gene is a critical growth regulator for astrocytes. In an effort to determine the contribution of the NF1 gene product, neurofibromin, to astrocyte growth regulation and NF1-associated astrocytoma formation, we generated astrocyte-specific Nf1 conditional knockout mice (Nf1GFAPCKO) by using Cre/LoxP technology. Transgenic mice were developed in which Cre recombinase was specifically expressed in astrocytes by embryonic day 14.5. Successive intercrossing with mice bearing a conditional Nf1 allele (Nf1flox) resulted in GFAP-Cre Nf1flox/flox (Nf1GFAPCKO) animals. No astrocytoma formation or neurological impairment was observed in Nf1GFAPCKO mice after 20 months, but increased numbers of proliferating astrocytes were observed in several brain regions. To determine the consequence of Nf1 inactivation at different developmental times, the growth properties of embryonic day 12.5 and postnatal day 2 Nf1 null astrocytes were analyzed. Nf1 null astrocytes exhibited increased proliferation but lacked tumorigenic properties in vitro and did not form tumors when injected into immunocompromised mouse brains in vivo. Collectively, our results suggest that loss of neurofibromin is not sufficient for astrocytoma formation in mice and that other genetic or environmental factors might influence NF1-associated glioma tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=0036293742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036293742&partnerID=8YFLogxK

U2 - 10.1128/MCB.22.14.5100-5113.2002

DO - 10.1128/MCB.22.14.5100-5113.2002

M3 - Article

C2 - 12077339

AN - SCOPUS:0036293742

VL - 22

SP - 5100

EP - 5113

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 14

ER -